Navigation Links
BioImagene Raises $26 M in Expansion Capital

BioImagene, the leading provider of affordable digital pathology solutions for cancer diagnosis and preclinical research, today announced the closing of a $26 million series D financing round led by Burrill & Company. Ascension Health Ventures, National Healthcare Services and existing investors Artiman Ventures and ICCP Ventures also joined the round with strong support.

CUPERTINO, Calif. (Business Wire EON) August 19, 2008 -- Mr. Yatin Mundkur, Artiman Ventures Partner and BioImagene board member noted "This follow-on investment reaffirms our commitment to the BioImagene team and their innovative products, and reinforces our belief in the enormous growth potential of digital pathology. We are very happy to guide the company through their next phase of future growth."

BioImagene CEO Mohan Uttarwar commented, "This latest infusion of capital from leading investors is a strong vote of confidence in our team, products and strategy. Our goal is to become the dominant player in this space by 2010. We are within range of our target and this funding will help us scale operations to support the rapidly increasing demand for affordable, integrated digital pathology systems. "

Digital pathology is the process of converting entire glass microscope slides into high-resolution, whole-slide digital images that can be viewed, managed and analyzed with a computer instead of a microscope—along with digital pathology management systems that help interpret the information generated from the digitized glass slide.

Digital pathology applications utilizing digital slides are gaining momentum as pathologists can access slide specimens and related data from any location in the world, fostering more efficient laboratory workflow, physician communication, education and research at a reasonable cost.

Investor Information

For more information on Artiman Ventures, please visit

For more information on Ascension Health Ventures, please visit

For more information on Burrill & Company, please visit

For more information on National Healthcare Services (NHS), please visit

For more information on ICCP Ventures, please visit

About BioImagene

BioImagene is a leading provider of total digital pathology solutions for applications including clinical diagnostics and drug discovery. BioImagene products are FDA -cleared for specific clinical applications, and are intended for research use for other applications.

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Low Vitamin D Raises Womens Hip Fracture Risk
2. NJHA Raises Questions Regarding Horizons Proposal to Convert to For-Profit Health Insurer
3. Stater Bros. Raises $200,000 for the Leukemia & Lymphoma Society
4. Summer Games Swap Raises Questions About Image, Oral Health
5. Dunkin Donuts Event Raises $800,000 for Cancer Research in One Day
6. The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance
7. GI Bleeding After Stroke Raises Death Risk
8. Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital
9. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
10. Secondhand Smoke Raises Stroke Risk for Spouses
11. CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign
Post Your Comments:
Related Image:
 BioImagene Raises $26 M in Expansion Capital 
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: